JB
Jason Bednar Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
50
Avg Return
Past Year
Past Year
1.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
58.3%
Neutral
41.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Medical Devices
Medical Distribution
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $5 |
23%
downside
| 1 | – |
–
| 4 Mar ‘26 9 hours ago |
|
|
|
Overweight
Maintained
| $178 |
23%
upside
| 1 | +6.7% |
0
%
| 20 Feb ‘26 12 days ago |
|
|
|
Overweight
Maintained
| $106 |
41%
upside
| 1 | -3.1% |
0
%
| 18 Feb ‘26 14 days ago |
|
|
|
Neutral
Reiterated
| $170 |
2%
downside
| 2 | -15% |
0
%
| 10 Feb ‘26 22 days ago |
|
|
|
Neutral
Reiterated
| $25 |
13%
downside
| 2 | – |
–
| 6 Feb ‘26 26 days ago |
|
|
|
Overweight
Maintained
| $220 |
19%
upside
| 1 | +4% |
0
%
| 5 Feb ‘26 27 days ago |
|
|
|
Overweight
Maintained
| $94 |
20%
upside
| 1 | -0.83% |
0
%
| 30 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $50 |
15%
upside
| 1 | +9.6% |
0
%
| 12 Jan ‘26 1 month ago |
|
|
|
Overweight
Upgraded
| $24 |
52%
upside
| 1 | -17% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Overweight
Reiterated
| $94 |
13%
upside
| 1 | -1.8% |
0
%
| 5 Dec ‘25 2 months ago |
|